Annual EPS
-$1.48
-$0.76-105.56%
December 31, 2023
Summary
- As of February 8, 2025, VRCA annual earnings per share is -$1.48, with the most recent change of -$0.76 (-105.56%) on December 31, 2023.
- During the last 3 years, VRCA annual EPS has risen by +$0.23 (+13.45%).
- VRCA annual EPS is now -1443.27% below its all-time high of -$0.10, reached on December 31, 2016.
Performance
VRCA EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.49
-$0.12-32.43%
September 30, 2024
Summary
- As of February 8, 2025, VRCA quarterly earnings per share is -$0.49, with the most recent change of -$0.12 (-32.43%) on September 30, 2024.
- Over the past year, VRCA quarterly EPS has increased by +$0.05 (+9.26%).
- VRCA quarterly EPS is now -23433.33% below its all-time high of $0.00, reached on September 30, 2022.
Performance
VRCA Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$1.84
+$0.05+2.65%
September 30, 2024
Summary
- As of February 8, 2025, VRCA TTM earnings per share is -$1.84, with the most recent change of +$0.05 (+2.65%) on September 30, 2024.
- Over the past year, VRCA TTM EPS has dropped by -$0.77 (-71.96%).
- VRCA TTM EPS is now -6333.57% below its all-time high of -$0.03, reached on March 31, 2017.
Performance
VRCA TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
VRCA EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -105.6% | +9.3% | -72.0% |
| 3 y3 years | +13.4% | -250.0% | -125.0% |
| 5 y5 years | -5.0% | -250.0% | -125.0% |
VRCA EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -105.6% | at low | <-9999.0% | +9.3% | -248.6% | +2.6% |
| 5 y | 5-year | -105.6% | +13.4% | <-9999.0% | +9.3% | -248.6% | +2.6% |
| alltime | all time | -1443.3% | +13.4% | <-9999.0% | +46.7% | -6333.6% | +2.6% |
Verrica Pharmaceuticals EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.49(+32.4%) | -$1.84(-2.6%) |
| Jun 2024 | - | -$0.37(-15.9%) | -$1.89(+7.4%) |
| Mar 2024 | - | -$0.44(-18.5%) | -$1.76(+19.7%) |
| Dec 2023 | -$1.48(+105.6%) | -$0.54(0.0%) | -$1.47(+37.4%) |
| Sep 2023 | - | -$0.54(+125.0%) | -$1.07(+102.7%) |
| Jun 2023 | - | -$0.24(+60.0%) | -$0.53(-19.8%) |
| Mar 2023 | - | -$0.15(+7.1%) | -$0.66(-19.6%) |
| Dec 2022 | -$0.72(-44.6%) | -$0.14(-6766.7%) | -$0.82(-20.4%) |
| Sep 2022 | - | $0.00(-100.6%) | -$1.03(-31.5%) |
| Jun 2022 | - | -$0.37(+19.4%) | -$1.50(-3.8%) |
| Mar 2022 | - | -$0.31(-11.4%) | -$1.56(+20.9%) |
| Dec 2021 | -$1.30(-24.0%) | -$0.35(-25.5%) | -$1.29(-11.6%) |
| Sep 2021 | - | -$0.47(+9.3%) | -$1.46(+3.5%) |
| Jun 2021 | - | -$0.43(+975.0%) | -$1.41(+3.7%) |
| Mar 2021 | - | -$0.04(-92.3%) | -$1.36(-20.5%) |
| Dec 2020 | -$1.71 | -$0.52(+23.8%) | -$1.71(+14.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$0.42(+10.5%) | -$1.50(+13.6%) |
| Jun 2020 | - | -$0.38(-2.6%) | -$1.32(+8.2%) |
| Mar 2020 | - | -$0.39(+25.8%) | -$1.22(+8.0%) |
| Dec 2019 | -$1.13(-19.9%) | -$0.31(+29.2%) | -$1.13(+0.9%) |
| Sep 2019 | - | -$0.24(-14.3%) | -$1.12(0.0%) |
| Jun 2019 | - | -$0.28(-6.7%) | -$1.12(-36.4%) |
| Mar 2019 | - | -$0.30(0.0%) | -$1.76(+14.7%) |
| Dec 2018 | -$1.41(+188.2%) | -$0.30(+25.0%) | -$1.53(-2.4%) |
| Sep 2018 | - | -$0.24(-73.9%) | -$1.57(+12.3%) |
| Jun 2018 | - | -$0.92(+1143.2%) | -$1.40(+161.8%) |
| Mar 2018 | - | -$0.07(-78.1%) | -$0.53(+9.3%) |
| Dec 2017 | -$0.49(+410.2%) | -$0.34(+395.9%) | -$0.49(+222.8%) |
| Sep 2017 | - | -$0.07(+24.0%) | -$0.15(+81.6%) |
| Jun 2017 | - | -$0.05(+92.0%) | -$0.08(+192.0%) |
| Mar 2017 | - | -$0.03 | -$0.03 |
| Dec 2016 | -$0.10 | - | - |
FAQ
- What is Verrica Pharmaceuticals annual earnings per share?
- What is the all time high annual EPS for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals annual EPS year-on-year change?
- What is Verrica Pharmaceuticals quarterly earnings per share?
- What is the all time high quarterly EPS for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals quarterly EPS year-on-year change?
- What is Verrica Pharmaceuticals TTM earnings per share?
- What is the all time high TTM EPS for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals TTM EPS year-on-year change?
What is Verrica Pharmaceuticals annual earnings per share?
The current annual EPS of VRCA is -$1.48
What is the all time high annual EPS for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high annual earnings per share is -$0.10
What is Verrica Pharmaceuticals annual EPS year-on-year change?
Over the past year, VRCA annual earnings per share has changed by -$0.76 (-105.56%)
What is Verrica Pharmaceuticals quarterly earnings per share?
The current quarterly EPS of VRCA is -$0.49
What is the all time high quarterly EPS for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high quarterly earnings per share is $0.00
What is Verrica Pharmaceuticals quarterly EPS year-on-year change?
Over the past year, VRCA quarterly earnings per share has changed by +$0.05 (+9.26%)
What is Verrica Pharmaceuticals TTM earnings per share?
The current TTM EPS of VRCA is -$1.84
What is the all time high TTM EPS for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high TTM earnings per share is -$0.03
What is Verrica Pharmaceuticals TTM EPS year-on-year change?
Over the past year, VRCA TTM earnings per share has changed by -$0.77 (-71.96%)